New Oracle Cloud Services Help Pharmas Accelerate Clinical Trial Site Feasibility Assessment and Patient Recruitment

Rhea-AI Summary

Oracle Life Sciences has launched two new cloud services: Oracle Site Feasibility and Oracle Patient Recruitment, aimed at accelerating clinical trials and reducing costs. Running on Oracle Cloud Infrastructure (OCI), these services leverage Electronic Health Record data to help pharmaceutical companies and researchers select trial sites and recruit patients more efficiently. The solutions address a significant industry challenge, as patient recruitment accounts for 32% of clinical trial costs, with $1.9 billion spent annually on recruitment. The new services enable faster site selection through feasibility queries across patient records and provide eligibility scoring for potential trial participants, helping streamline the recruitment process while maintaining HIPAA compliance.

Positive

• New cloud services directly address the largest clinical trial cost component (32% of total)
• Services leverage existing EHR data to improve site selection efficiency
• Solution helps reduce the $1.9 billion annual recruitment spending
• Platform ensures HIPAA compliance and security for protected health information

Negative

• None.

Insights

Healthcare Technology Analyst

Oracle's new clinical trial services represent a significant advancement in the pharmaceutical research space. The integration of Oracle Cloud Infrastructure with Electronic Health Record data creates a powerful platform for optimizing clinical trial operations. The ability to reduce the $1.9 billion annual recruitment spend while improving site selection efficiency addresses a major pain point in the industry.

The platform's HIPAA-compliant infrastructure and ability to process deidentified EHR data provides a competitive advantage in the $40 billion clinical trials market. The focus on reducing the 32% of costs attributed to patient recruitment could significantly improve profit margins for pharmaceutical companies and CROs using the platform.

The business impact extends beyond immediate cost savings - faster trial completion means accelerated time-to-market for new drugs, potentially worth billions in additional revenue for pharmaceutical companies. This positions Oracle strongly in the growing clinical trial technology market.

Developments are the latest in Oracle's commitment to bridge the gap between clinical research and patient care to help speed the development of and access to breakthrough treatments   

NASHVILLE, Tenn., Oct. 29, 2024 /PRNewswire/ -- Oracle Health Summit -- To help life sciences organizations accelerate and reduce the cost and complexity of clinical trials so they can get lifesaving treatments to market faster, Oracle Life Sciences today announced Oracle Site Feasibility and Oracle Patient Recruitment Cloud Services. Running on Oracle Cloud Infrastructure (OCI), the new Oracle Life Sciences services benefit from best-in-class security and trust in handling and storing Protected Health Information in compliance with HIPAA regulations. In addition, OCI's high performance and availability mean these new solutions, coupled with Oracle's Real World Data assets and life science and clinical applications, help pharmaceutical companies, CROs and researchers to select clinical trial sites and recruit patients more quickly.

"Patient recruitment is the cornerstone of any clinical trial, but identifying the right sites and recruiting the right patients at scale is difficult, time-consuming, and costly," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "Our new site feasibility and patient recruitment cloud services are an example of how Oracle's extensive expertise in life sciences and healthcare are bridging the gap between clinical research and patient care. We can provide insights based on our secure, authorized, and vast Electronic Health Record data that helps sponsors and CROs to intelligently select clinical trial sites and enable site study teams to identify and enroll qualified patients more efficiently and effectively."

According to Deloitte research¹, patient recruitment accounts for 32% of clinical trial costs, making it the largest expense in the process. Additionally, $1.9 billion is spent on recruitment annually,² even though 72% of trial participants are already patients at a site. Oracle Site Feasibility and Oracle Patient Recruitment can help life sciences organizations overcome these challenges and dramatically reduce the cost of running clinical trials.

Through the existing Study Startup solution and Oracle's extensive deidentified Electronic Health Record (EHR) data from participating healthcare systems, Oracle Site Feasibility Cloud Service enables life sciences organizations to quickly and easily identify the most advantageous sites for their clinical trials. Within activated clinical trial sites, Oracle Patient Recruitment Cloud Service can increase enrollment efficiency by informing authorized study teams of identified patients within their health system who could potentially meet trial criteria based on their clinical profile.

Activate sites faster and accelerate study timelines

With Oracle Site Feasibility, life science organizations can accelerate the site-selection process and have more visibility into untapped sites. The new service enables life science organizations to more quickly find viable clinical trial site locations by surfacing trial-specific eligible and partially eligible patients from participating healthcare facilities. This solution uses Oracle's deidentified EHR clinical data to run feasibility queries across patient records, analyzing key data points, such as past site performance and qualified patients per site. This data granularity helps life science organizations to intelligently select sites with the highest volume of potential eligible patients.

Recruit the right patients more quickly

Oracle Patient Recruitment is available globally for life sciences customers to help activate sites faster and provide deeper patient insights to help study teams be more aware of any retention or dropout risks and recruit the right patients for the trial. It uses Health Data Intelligence (HDI) as its underlying technology infrastructure to surface data directly from the EHR and identify eligible and partially eligible patients for potential trial participation.

Oracle Patient Recruitment calculates an eligibility score for qualified patients and provides important insights to the study team about why a patient qualifies for a trial or where they may fall short. This level of detail lets study teams quickly identify what next steps should be taken with the trial candidate and eliminates time wasted searching for additional context in the medical record. Oracle Patient Recruitment also incorporates health system registration and scheduling data, giving study teams visibility to upcoming and past appointment details. Using these additional insights, the study team can customize a visit schedule based on the patient's unique situation to help ensure the patient does not drop out – another step in putting the patient's care first. 

For more information about Oracle Site Feasibility and Oracle Patient Recruitment Cloud Services, visit: https://www.oracle.com/life-sciences/

To join segments of the Oracle Health Summit virtually, visit: https://www.oracle.com/health/health-summit/

About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

¹ Taylor K, Properzo, F, et al. Intelligent clinical trials. Deloitte Centre for Health Insights. 2020. https://www2.deloitte.com/content/dam/insights/us/articles/22934_intelligent-clinical-trials/DI_Intelligent-clinical-trials.pdf
² Idnay B, Fang Y, Butler A, et al. Uncovering key clinical trial features influencing recruitment. J Clin Transl Sci. 2023 Sep 4;7(1):e199. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565197/

View original content to download multimedia:https://www.prnewswire.com/news-releases/new-oracle-cloud-services-help-pharmas-accelerate-clinical-trial-site-feasibility-assessment-and-patient-recruitment-302289032.html

SOURCE Oracle

FAQ

What are the new cloud services announced by Oracle (ORCL) for clinical trials?

Oracle announced two new cloud services: Oracle Site Feasibility and Oracle Patient Recruitment Cloud Services, designed to accelerate clinical trial site selection and patient recruitment processes.

How much do patient recruitment costs represent in clinical trials according to Oracle (ORCL)?

According to Deloitte research cited in the announcement, patient recruitment accounts for 32% of clinical trial costs, with $1.9 billion spent annually on recruitment.

What is the main benefit of Oracle's (ORCL) new Site Feasibility Cloud Service?

The main benefit is the ability to quickly identify advantageous trial sites by analyzing deidentified EHR data to find locations with the highest volume of potentially eligible patients.

How does Oracle (ORCL) Patient Recruitment Cloud Service improve trial enrollment?

It improves enrollment by calculating patient eligibility scores, providing insights to study teams about patient qualification, and incorporating health system scheduling data to optimize visit schedules.